Pharmahungary Group
PHARMAHUNGARY 2000 Kft.
Provider of preclinical and clinical R&D services for pharmaceutical and medical device development.
Bemutatkozás
Pharmahungary Group is an R&D company with over 20 years of experience and more than 300 development projects. It offers comprehensive preclinical R&D services, including cardiovascular, metabolic, renal, inflammation, and neuropathy disease models, large animal studies, and specialized testing. The company also provides clinical R&D services for medical devices, in vitro diagnostics, combination products, and drugs, encompassing full CRO support, regulatory, and ethics committee management. Additionally, Pharmahungary Group develops novel in-house R&D projects for diagnostics and therapeutics, which are available for out-licensing, co-development, and investment.
Szolgáltatások, tevékenységek
- Preclinical R&D services for cardiovascular diseases
- Preclinical R&D services for metabolic diseases
- Preclinical R&D services for renal diseases
- Preclinical R&D services for inflammation diseases
- Preclinical R&D services for neuropathy diseases
- Provision of large animal models (porcine, Göttingen minipig)
- Conducting multicenter preclinical proof-of-concept studies
- Provision of cardiac electrophysiology models (voltage clamp, microelectrode technique)
- Matrix Metalloproteinase Inhibitor Screening
- Testing cardioprotective compounds on acute and chronic coronary occlusion-induced myocardial ischemia/reperfusion
- Testing cardioprotective compounds on myocardial infarction
- Testing cardioprotective compounds on preconditioning and postconditioning
- Testing compounds for heart failure induced by chronic coronary occlusion-induced infarction
- Testing compounds for heart failure induced by cardiotoxic agents
- Testing cardioprotective compounds in organ storage models
- Testing vascular functions in hyperlipidemia/atherosclerosis models
- Testing vascular functions in nitrate-tolerance models
- Evaluation of antidiabetic compounds in type 1 diabetic models (STZ, Goto-Kakizaki, Zucker Diabetic Fatty)
- Evaluation of antidiabetic compounds in type 2 diabetic models (STZ, Goto-Kakizaki, Zucker Diabetic Fatty)
- Evaluation of compounds acting on the nitric oxide-cGMP system
- Evaluation of compounds acting on peroxynitrite formation
- Testing antiplatelet compounds in platelet aggregation systems
- Testing antioxidant agents in cardiovascular disease models
- Testing antioxidant agents in metabolic disease models
- Evaluation of cardiac heat-shock protein (HSP) inducers
- Evaluation of matrix metalloproteinase (MMP) inhibitors
- Clinical R&D services for medical devices
- Clinical R&D services for In Vitro Diagnostics
- Clinical R&D services for combination products
- Clinical R&D services for drugs (small molecules, biologics, ATMPs)
- Management of Investigator Initiated Trials (IITs)
- Management of niche clinical trials
- Scientific consultancy for preclinical and clinical development
- Medical writing services
- Strategic regulatory consultancy
- Strategic ethics committee consultancy
- Planning clinical trials
- Organizing clinical trials
- Managing clinical trials
- Conducting feasibility studies for clinical trials
- National Competent Authority submission for clinical trials
- Ethics Committee submission for clinical trials
- Monitoring clinical trials
- Site management for clinical trials
- Contract management for clinical trials
- Training on medical device development
- Training on medical device regulation
- Training on EU standards for medical devices
- Development of novel in-house R&D projects for diagnostics
- Development of novel in-house R&D projects for therapeutics
- Out-licensing of R&D projects
- Co-development of R&D projects
- Seeking investment for R&D projects
- Development of ProtectomiR (cytoprotective miRNA targets)
- Development of Infarnosys (biomarker diagnostic system for acute myocardial ischemia/reperfusion injury)
- Development of Vezics (modular and scalable chromatography platform for exosome isolation)
- Development of miRNAtarget (bioinformatics project for target prediction)
- Development of Vigilace (bioinformatics project for prediction and determination of adverse events and drug interactions)
- Development of InfarctSizeAI (AI-assisted analysis of infarct regions and sizes on animal heart images)
Cím és elérhetőség
Pharmahungary Group OfficeSzékhely
1031 Budapest, 7 Záhony street, Graphisoft Park
Cégadatok
- Cégnév
- PHARMAHUNGARY 2000 Kft.
- Székhely
- Hajnoczy str. 6., Szeged H-6722, Hungary
- Adószám
- 13109202-2-06
- Cégjegyzékszám
- Cg. 06-09-008744
- Postacím / telephely
- Graphisoft Park, Building I, Zahony str. 7., Budapest H-1031, Hungary
A cégadatok a vállalkozás saját weboldalán közzétett impresszumból származnak.